CanSino Biologics Inc

688185

Company Profile

  • Business description

    CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

  • Contact

    185 South Avenue
    401-420, 4th Floor, Biomedical Park
    TEDA West District
    Tianjin
    CHN

    T: +86 4009222099

    https://www.cansinotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,105

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,826.1048.200.55%
CAC 407,878.46111.751.44%
DAX 4024,549.56342.651.42%
Dow JONES (US)44,458.30217.540.49%
FTSE 1008,867.0212.840.15%
HKSE23,911.4619.140.08%
NASDAQ20,611.34192.870.94%
Nikkei 22539,618.13203.15-0.51%
NZX 50 Index12,737.5931.02-0.24%
S&P 5006,263.2637.740.61%
S&P/ASX 2008,589.7051.100.60%
SSE Composite Index3,502.779.720.28%

Market Movers